日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

STING synergizes with TOX suppressing HO-1 expression to trigger ferroptosis in tumor-infiltrating CD8+ T cell and immunotherapy resistance

STING 与 TOX 协同抑制 HO-1 表达,从而诱导肿瘤浸润 CD8+ T 细胞发生铁死亡,并导致免疫治疗耐药。

Zhu, Qian; Zhang, Jun-Bao; Nie, Cai-Ping; Liu, Xiu-Feng; Zhan, Liang-Ping; Li, Ming; Zeng, Xi-Liang; He, Jia; Huang, He; Xia, Xiao-Jun; Gao, Song; Zhang, Xiao-Shi; Li, Jiang

Cuproptosis in atrazine-induced hepatotoxicity: ATOX1 as a therapeutic target for lycopene-mediated protection

阿特拉津诱导肝毒性中的铜凋亡:ATOX1作为番茄红素介导保护作用的治疗靶点

Li, Nuo-Wa; Yao, Xin; Lu, Wei-Hong; Zhang, Yu-Qian; Liu, Ying-Ying; Zhang, Tian-Tian; Zhao, Yang; Li, Jin-Long

Upregulation of TNFR2 Precedes TOX Expression by Exhausted T cells and Restricts Antitumor and Antiviral Immunity.

TNFR2 的上调先于耗竭 T 细胞的 TOX 表达,并限制抗肿瘤和抗病毒免疫。

Hoyt-Miggelbrink Alexandra M, Waibl Polania Jessica, Wachsmuth Luke, Lorrey Selena, Mohan Aditya, Hardigan Andrew, Blandford Emily, Lerner Emily, Wilkinson Daniel, Hotchkiss Kelly M, Cook Sarah, Hemmers Saskia, Patel Anoop, Ayasoufi Katayoun, Fecci Peter

CAR HEMATOTOX independently predicts outcomes after CD19 CAR-T therapy for acute lymphoblastic leukemia

CAR HEMATOTOX 可独立预测 CD19 CAR-T 疗法治疗急性淋巴细胞白血病后的预后。

Valtis, Yannis K; Lin, Chenyu; Nemirovsky, David; Devlin, Sean; Rejeski, Kai; Curran, Kevin J; Wang, Xiuyan; Shah, Nirali N; Jeyakumar, Nikeshan; Miller, Katharine; Zhang, Amy; Kota, Vamsi K; Al Darobi, Ali H; Muhsen, Ibrahim; Sasine, Joshua; Aldoss, Ibrahim; Advani, Anjali S; Reshef, Ran; Chen, Evan C; Kopmar, Noam; Tsai, Stephanie B; Hilal, Talal; Shah, Bijal D; Faramand, Rawan; Solh, Melhem M; Tan, Virginia; Bezerra, Evandro; Battiwalla, Minoo; Ramakrishnan, Aravind; Mathews, John; Shaughnessy, Paul; Mountjoy, Luke; Hoeg, Rasmus T; Dykes, Kaitlyn C; Logan, Aaron C; Kumaran, Muthu V; Schwartz, Marc; Tracy, Sean; Moore, Jozal; Odstrcil Bobillo, Silvina; Frey, Noelle V; Connor, Matthew; Ladha, Abdullah; Dholaria, Bhagirathbhai; Sutherland, Katherine; Roloff, Gregory W; Muffly, Lori S; Park, Jae H

CRISPR-Cas9 screening identifies ATOX1-driven cisplatin resistance mechanisms in liver cancer and evaluates targeted inhibitor efficacy.

CRISPR-Cas9 筛选可识别肝癌中由 ATOX1 驱动的顺铂耐药机制,并评估靶向抑制剂的疗效。

Hu Chujiao, Tai Huading, Zhu Renguang, Shu Zhengyu, Guo Guanghao, Ma Dan, Zuo Shi, Tang Lei, Zeng Zhirui

Reduced circulating STOX1 is associated with inflammatory cytokines and insulin resistance in obese individuals: a cross-sectional study.

肥胖个体中循环 STOX1 减少与炎症细胞因子和胰岛素抵抗有关:一项横断面研究。

Wang Yanping, Xiang Mingliang, Jiang Xianmei, Shuai Mingsha, Jian Li, Geng Shan

Safety concerns associated with high-dose continuous infusion of cefepime among critically ill patients with mild renal impairment to augmented renal clearance at a level 1 trauma center: CEFTOX study

在I级创伤中心,对轻度肾功能损害至肾清除率增强的危重患者进行高剂量头孢吡肟持续输注的安全隐患:CEFTOX研究

Lamamri, Myriam; Rutman, Charlotte; Codorniu, Anais; Holleville, Mathilde; Sigaut, Stéphanie; Weiss, Emmanuel; Jeantrelle, Caroline

Gender Differences in Post-Stroke Spasticity Patients Treated with OnabotulinumtoxinA: Insights from the BOTOX Economic Spasticity Trial (BEST)

使用A型肉毒杆菌毒素治疗中风后痉挛患者的性别差异:来自BOTOX经济痉挛试验(BEST)的启示

Verduzco-Gutierrez, Monica; Kaloti, Reema; Beckley, Akinpelumi A; Hussain, Adil Syed; Desai, Sima A; Becker Ifantides, Kimberly; Romanoski, Natasha L

Mechanisms of FOXK1-regulated glycolipid metabolism in mediating TOX-induced histone lactylation to promote CD8⁺ T cell exhaustion in high-grade serous ovarian cancer.

FOXK1 调控的糖脂代谢机制介导 TOX 诱导的组蛋白乳酸化,从而促进高级别浆液性卵巢癌中 CD8+ T 细胞的耗竭。

Li, Min

m6A Modification of ATOX1 Inhibits Acute Myeloid Leukemia Progression by Promoting Cuproptosis.

m6A修饰ATOX1通过促进铜凋亡抑制急性髓系白血病进展。

Peng Jiapei, Fu Xiao, Li Shujun, Hu Changmei, Zhao Xielan, Peng Jie